In response to: “Innovative cellular therapies for autoimmune diseases: expert-based position statement and clinical practice recommendations from the EBMT practice harmonization and guidelines committee” by Greco et al.
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-12-01
|
| Series: | EClinicalMedicine |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2589537024004978 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1846160351864815616 |
|---|---|
| author | James F. Howard, Jr. Susan M. Manzi Milos D. Miljkovic Tuan Vu Tahseen Mozaffar |
| author_facet | James F. Howard, Jr. Susan M. Manzi Milos D. Miljkovic Tuan Vu Tahseen Mozaffar |
| author_sort | James F. Howard, Jr. |
| collection | DOAJ |
| format | Article |
| id | doaj-art-be59365a237b43e2aa58ca624cad5f85 |
| institution | Kabale University |
| issn | 2589-5370 |
| language | English |
| publishDate | 2024-12-01 |
| publisher | Elsevier |
| record_format | Article |
| series | EClinicalMedicine |
| spelling | doaj-art-be59365a237b43e2aa58ca624cad5f852024-11-22T07:38:40ZengElsevierEClinicalMedicine2589-53702024-12-0178102918In response to: “Innovative cellular therapies for autoimmune diseases: expert-based position statement and clinical practice recommendations from the EBMT practice harmonization and guidelines committee” by Greco et al.James F. Howard, Jr.0Susan M. Manzi1Milos D. Miljkovic2Tuan Vu3Tahseen Mozaffar4University of North Carolina at Chapel Hill, Chapel Hill, NC, USA; Corresponding author.Allegheny Health Network, Lupus Center of Excellence, Pittsburgh, PA, USACartesian Therapeutics, Gaithersburg, MD, USAUniversity of South Florida, Tampa, FL, USAUniversity of California Irvine, CA, USAhttp://www.sciencedirect.com/science/article/pii/S2589537024004978 |
| spellingShingle | James F. Howard, Jr. Susan M. Manzi Milos D. Miljkovic Tuan Vu Tahseen Mozaffar In response to: “Innovative cellular therapies for autoimmune diseases: expert-based position statement and clinical practice recommendations from the EBMT practice harmonization and guidelines committee” by Greco et al. EClinicalMedicine |
| title | In response to: “Innovative cellular therapies for autoimmune diseases: expert-based position statement and clinical practice recommendations from the EBMT practice harmonization and guidelines committee” by Greco et al. |
| title_full | In response to: “Innovative cellular therapies for autoimmune diseases: expert-based position statement and clinical practice recommendations from the EBMT practice harmonization and guidelines committee” by Greco et al. |
| title_fullStr | In response to: “Innovative cellular therapies for autoimmune diseases: expert-based position statement and clinical practice recommendations from the EBMT practice harmonization and guidelines committee” by Greco et al. |
| title_full_unstemmed | In response to: “Innovative cellular therapies for autoimmune diseases: expert-based position statement and clinical practice recommendations from the EBMT practice harmonization and guidelines committee” by Greco et al. |
| title_short | In response to: “Innovative cellular therapies for autoimmune diseases: expert-based position statement and clinical practice recommendations from the EBMT practice harmonization and guidelines committee” by Greco et al. |
| title_sort | in response to innovative cellular therapies for autoimmune diseases expert based position statement and clinical practice recommendations from the ebmt practice harmonization and guidelines committee by greco et al |
| url | http://www.sciencedirect.com/science/article/pii/S2589537024004978 |
| work_keys_str_mv | AT jamesfhowardjr inresponsetoinnovativecellulartherapiesforautoimmunediseasesexpertbasedpositionstatementandclinicalpracticerecommendationsfromtheebmtpracticeharmonizationandguidelinescommitteebygrecoetal AT susanmmanzi inresponsetoinnovativecellulartherapiesforautoimmunediseasesexpertbasedpositionstatementandclinicalpracticerecommendationsfromtheebmtpracticeharmonizationandguidelinescommitteebygrecoetal AT milosdmiljkovic inresponsetoinnovativecellulartherapiesforautoimmunediseasesexpertbasedpositionstatementandclinicalpracticerecommendationsfromtheebmtpracticeharmonizationandguidelinescommitteebygrecoetal AT tuanvu inresponsetoinnovativecellulartherapiesforautoimmunediseasesexpertbasedpositionstatementandclinicalpracticerecommendationsfromtheebmtpracticeharmonizationandguidelinescommitteebygrecoetal AT tahseenmozaffar inresponsetoinnovativecellulartherapiesforautoimmunediseasesexpertbasedpositionstatementandclinicalpracticerecommendationsfromtheebmtpracticeharmonizationandguidelinescommitteebygrecoetal |